Skip to main content

WEBINAR: the Role of Tumor-Specific PET imaging and SBRT in the Management of Prostate Cancer!


Thursday, March 25, 2021 - 8:28

<p>IBA invites you to attend a free webinar presented by 3 leading personalities in Nuclear Medicine, Radiation Oncology and Medical Physics: Dr Jeremie Calais, PD Dr. med. Stefan Körber and Dr. Kai Schubert.&nbsp;</p> <p>In this webinar, the speakers will highlight the synergy between highly sensitive imaging, the definition of an intermediate stage between non-disseminated tumor and widespread metastatic disease (oligometastatic state) and high-precision radiation therapy (Stereotactic Body Radiation Therapy - SBRT) focused to treat the oligometastatic lesions.</p> <p>When? April 26th, 5-6 pm CET</p> <p><a href="">&nbsp;REGISTER</a></p> <p><br /> What will you learn from the webinar ?&nbsp;</p> <p><br /> <strong>•&nbsp;&nbsp; &nbsp; &nbsp;Impact of PSMA PET on management of patients with oligo metastatic prostate cancer</strong></p> <p><br /> By Dr. Jeremie Calais, Director of the Clinical Research Program of the Nuclear Medicine and Theranostics Division at UCLA.&nbsp;</p> <p>Dr Calais will cover the concept of oligometastatic disease in prostate cancer patients and the impact of PSMA PET imaging on the therapy management of those patients. &nbsp;</p> <p><br /> <strong>•&nbsp;&nbsp; &nbsp;The Role of SBRT in the treatment of oligometastatic prostate cancer: Why &amp; how SBRT for these patients</strong></p> <p>By PD Dr. med. Stefan Körber, &nbsp;First Senior Medical Doctor at Clinic for Radiation Oncology and Radiation Therapy at University Clinic of Heidelberg, Germany</p> <p>Dr. Körber will describe how the oligometastatic status of prostate cancer patients is defined on the basis of PSMA PET/CT and which strategies and modalities are applied for SBRT treatment of these patients<br /> &nbsp;&nbsp;</p> <p><br /> <strong>•&nbsp;&nbsp; &nbsp;Quality assurance for SBRT treatments</strong></p> <p>By Dr. Kai Schubert, Medical Physicist at Clinic for Radiation Oncology and Radiation Therapy at University Clinic of Heidelberg, Germany.</p> <p>The extremely high precision of SBRT requires an extensive program of Quality Assurance, both for the treatment machines as for the patient-specific treatment plans. Dr. Schubert will explain current strategies and future developments in this field.</p> <p><br /> <a href="">&nbsp;REGISTER</a><br /> &nbsp;</p>

More news